chartreusin

Known as: lambdamycin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1955-2016
012319552015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Natural products of the benzonaphthopyranone class, such as chartreusin, elsamicin A, gilvocarcin, and polycarcin, represent… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2005
2005
Chartreusin is a potent antitumor agent with a mixed polyketide-carbohydrate structure produced by Streptomyces chartreusis… (More)
Is this relevant?
2002
2002
Characterization of the thermodynamics of DNA- drug interactions is a very useful part in rational drug design. Isothermal… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?
1991
1991
Three DNA restriction fragments designated tyrT, 102-mer and 70-mer, have been used as substrates for footprinting studies using… (More)
Is this relevant?
1990
1990
In order to overcome the rapid biliary excretion of chartreusin, which diminished its activity when administered iv, a series of… (More)
  • figure 2
  • table 1
  • table 2
  • table 4
  • table 3
Is this relevant?
1986
1986
New antitumor antibiotics, elsamicins A and B, were isolated from the culture broth of an unidentified actinomycete strain J907… (More)
Is this relevant?
1983
1983
Chartreusin, an antitumor and antibacterial antibiotic, was found to inhibit negatively superhelical DNA-relaxation catalyzed by… (More)
Is this relevant?
1979
1979
The apparent aqueous solubility of the water-insoluble cytotoxic agent, chartreusin, was increased at neutral pH in the presence… (More)
Is this relevant?
1978
1978
Chartreusin (CT), an antibiotic produced by Strepto myceschartreusls,was recentlyfoundto be activeagainst experimental tumors B16… (More)
  • table 1
  • table 5
Is this relevant?
1977
1977
Chartreusin has exhibited significant therapeutic activity against three experimental mouse tumors (ascitic P388, L1210 leukemia… (More)
  • table 1
  • table 2
Is this relevant?